DEP HER2 zirconium - Starpharma
Alternative Names: DEP® HER2-zirconiumLatest Information Update: 18 Sep 2023
At a glance
- Originator Starpharma
- Class Antineoplastics; Radioisotopes; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer; Cancer